Behandlingsniveau og behandlingsstop ved benign lungesygdom

Anita Rath Sørensen; Elisabeth Bendstrup; Anders Løkke; Ingrid Louise Titlestad; Jens Ulrik Jensen; Laura Thomsen; Nassim Roberts; Pia Gjørup; Saher Shaker; Svend Gundestrup; Torgny Wilcke; Ulla Møller Weinreich; Kristoffer Marsaa

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Anita Rath Sørensen, Elisabeth Bendstrup, Anders Løkke, Ingrid Louise Titlestad, Jens Ulrik Jensen, Laura Thomsen, Nassim Roberts, Pia Gjørup, Saher Shaker, Svend Gundestrup, Torgny Wilcke, Ulla Møller Weinreich, Kristoffer Marsaa

Institut for Klinisk Medicin

Abstract

The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

Bidragets oversatte titel	Treatment limitations or discontinuation in patients with benign pulmonary diseases
Originalsprog	Dansk
Artikelnummer	V04180270
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	39
Antal sider	4
ISSN	0041-5782
Status	Udgivet - 2018

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/behandlingsniveau-og-behandlingsstop-ved-benign-lungesygdom

Citationsformater

Sørensen, A. R., Bendstrup, E., Løkke, A., Titlestad, I. L., Jensen, J. U., Thomsen, L., Roberts, N., Gjørup, P., Shaker, S., Gundestrup, S., Wilcke, T., Weinreich, U. M., & Marsaa, K. (2018). Behandlingsniveau og behandlingsstop ved benign lungesygdom. Ugeskrift for Laeger, 180(39), Artikel V04180270. http://ugeskriftet.dk/videnskab/behandlingsniveau-og-behandlingsstop-ved-benign-lungesygdom

Sørensen, AR, Bendstrup, E, Løkke, A, Titlestad, IL, Jensen, JU, Thomsen, L, Roberts, N, Gjørup, P, Shaker, S, Gundestrup, S, Wilcke, T, Weinreich, UM & Marsaa, K 2018, 'Behandlingsniveau og behandlingsstop ved benign lungesygdom', Ugeskrift for Laeger, bind 180, nr. 39, V04180270. <http://ugeskriftet.dk/videnskab/behandlingsniveau-og-behandlingsstop-ved-benign-lungesygdom>

@article{9cbc85ce3d6c4786969fc99e8b6e792b,

title = "Behandlingsniveau og behandlingsstop ved benign lungesygdom",

abstract = "The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.",

author = "S{\o}rensen, {Anita Rath} and Elisabeth Bendstrup and Anders L{\o}kke and Titlestad, {Ingrid Louise} and Jensen, {Jens Ulrik} and Laura Thomsen and Nassim Roberts and Pia Gj{\o}rup and Saher Shaker and Svend Gundestrup and Torgny Wilcke and Weinreich, {Ulla M{\o}ller} and Kristoffer Marsaa",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "39",

}

TY - JOUR

T1 - Behandlingsniveau og behandlingsstop ved benign lungesygdom

AU - Sørensen, Anita Rath

AU - Bendstrup, Elisabeth

AU - Løkke, Anders

AU - Titlestad, Ingrid Louise

AU - Jensen, Jens Ulrik

AU - Thomsen, Laura

AU - Roberts, Nassim

AU - Gjørup, Pia

AU - Shaker, Saher

AU - Gundestrup, Svend

AU - Wilcke, Torgny

AU - Weinreich, Ulla Møller

AU - Marsaa, Kristoffer

PY - 2018

Y1 - 2018

N2 - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

AB - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

M3 - Tidsskriftartikel

C2 - 30274574

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 39

M1 - V04180270

ER -

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater